Google
×
Ticagrelor seems to be a better option than clopidogrel for patients with acute coronary syndromes for whom an early invasive strategy is planned.
Jan 14, 2010 · Ticagrelor seems to be a better option than clopidogrel for patients with acute coronary syndromes for whom an early invasive strategy is ...
Ticagrelor seems to be a better option than clopidogrel for patients with acute coronary syndromes for whom an early invasive strategy is planned.
Jan 23, 2010 · Methods At randomisation, an invasive strategy was planned for 13 408 (72·0%) of 18 624 patients hospitalised for acute coronary syndromes ...
People also ask
Jun 17, 2011 · The PLATelet inhibition and patient Outcomes (PLATO) trial found that the reversibly binding oral P2Y12-inhibitor ticagrelor was superior to clopidogrel.
Apr 11, 2014 · The incidence of the primary composite endpoint was reduced with ticagrelor vs. clopidogrel (10.0 vs. 12.3%; HR 0.83; 95% CI = 0.74–0.93; P = 0.0013)
Nov 8, 2010 · Ticagrelor, a reversible oral P2Y12-receptor antagonist, provides faster, greater, and more consistent platelet inhibition than clopidogrel.
The PLATO (Platelet Inhibition and Patient Outcomes) trial found that ticagrelor was superior to clopidogrel for the prevention of cardiovascular and total ...
Aug 29, 2010 · The PLATelet inhibition and patient Outcomes (PLATO) trial showed that ticagrelor was superior to clopidogrel for the prevention of CV death, ...
Sep 1, 2012 · Dyspnea and ventricular pauses were more common during ticagrelor than clopidogrel treatment, with no evidence of an age-by-treatment ...